Stock Movers DBV Drug, SAP Fears, BP on Sanctions
Dec 17, 2025
DBV Technologies celebrates a major breakthrough with its experimental skin patch for peanut allergies in children. Tensions rise as the U.S. threatens retaliation against European tech firms, potentially impacting giants like SAP and Accenture. Meanwhile, a U.S. blockade of Venezuelan oil tankers sends ripples through the market, boosting BP and other oil stocks. It's a whirlwind of corporate strategies, international relations, and health innovations!
AI Snips
Chapters
Transcript
Episode notes
Breakthrough Peanut Patch Shows Promise
- DBV's redesigned peanut allergy skin patch succeeded in desensitizing children aged four to seven after a year of use.
- The company plans to seek US regulatory approval in the first half of 2026, targeting a large pediatric patient population.
Host Shares Personal Peanut-Allergy Link
- Caroline Hepker disclosed she has a personal history with peanut allergy, noting the product would have mattered earlier in her life.
- She emphasized the large affected population to underline the patch's potential impact.
US Threatens Retaliation Over Tech Taxes
- The US threatened trade retaliation against select European firms in response to EU plans to tax big American tech companies.
- Stocks like SAP, Capgemini and Spotify fell then partly recovered as markets weighed how concrete those threats were.